Study shows moxifloxacin safe in treatment of bacterial conjunctivitis

May 6, 2003

Ft. Lauderdale-Results of an FDA Phase III study demonstrate that moxifloxacin ophthalmic solution 0.5% (Vigamox, Alcon) is a safe and effective treatment for bacterial conjunctivitis in adults and children as young as 1 month old, said Harold R. Katz, MD, speaking on behalf of the Moxifloxacin Conjunctivitis Study Group.